Drug Interactions & Adverse Effects

Resources: 18

COVID-19 Update for People with HIV

Three sets of training slides covering what providers treating people with HIV should know about COVID-19. Overall learning objectives include identifying risk factors for and strategies to reduce sev...

Publication Date
04/09/2020

Hepatitis C Online

Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. This project is funded by the Centers for Disease Control and Prevention (CDC).

Th...

Publication Date
01/15/2021

ART Drug Interactions

Training slides review potential ARV drug-drug interactions and identify resources for the evaluation of drug-drug interactions.

Documents with preview

Publication Date
09/22/2021

AIDSinfo Illustrated Glossary

This digital glossary of HIV-related terms includes both lay and scientific descriptions and illustrations. Materials are in the public domain and may be used freely. The glossary and images are also...

Publication Date
04/14/2023

HIV Medication Adherence Strategies

Training slides learning objectives include:

  • Identifying factors that affect medication adherence for people with HIV
  • Recognizing the importance of a patient-centered approach to antiretroviral therapy...
Publication Date
08/02/2023

Hepatitis C: Drug-Drug Interactions

Training slides learning objections include:

  • Understanding the mechanism of action for drug interactions with hepatitis C medications
  • Recognizing which medications should be avoided in co-administration...
Publication Date
08/09/2023

National HIV Curriculum & Promotional Resources

The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention. The 37 lessons and corresponding question bank topics offer...

Type
Publication Date
09/05/2023

Resources: 4

Articles: 7

Cobicistat and Stribild Use in Patients with Renal Insufficiency

Co-Author: Susa Coffey, MD; Medical Editor, AETC National Resource Center

An open-label study is evaluating the renal safety of elvitegravir/cobicistat/emtricitabine/tenofovir (Stribild, or the "quad" pill) and cobicistat. For those patients with mild-to-moderate renal impairment (estimated glomerula...

Ian
McNicholl

Pitavastatin and Darunavir/Ritonavir

Coauthor: Susa Coffey, MD; Medical Editor, AETC National Resource Center

Treatment of dyslipidemia is often complicated by drug interactions between statins and antiretrovirals. Pitavastatin is one of the newer statins approved and is one of the few that is not metabolized primarily by the CYP450 3A4...

Ian
McNicholl

Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)

Treatment of tuberculosis (TB) in HIV-infected persons remains challenging, in part because of drug interactions between rifampin and some ARVs that may compromise antiretroviral therapy (ART). Three studies presented at CROI provide clinicians with additional guidance on how to manage certain inter...